By: IPP Bureau
Last updated : April 21, 2026 6:20 pm
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
AstraZeneca Pharma India, in collaboration with STEMI India, has announced the launch of India Coronary Conquest (ICC) 2026, a clinician-led national initiative aimed at strengthening expertise in complex percutaneous coronary intervention (PCI) among early- to mid-career interventional cardiologists.
Unveiled in Bangalore on April 21, 2026, ICC 2026 is designed as a competitive, case-based learning platform where participants present real-world complex PCI cases. The programme emphasises intravascular imaging, vascular physiology, guideline-aligned decision-making, complication management, and procedural safety, with a strong focus on peer-reviewed critique and practical learning.
Against the backdrop of rising chronic disease burden, where cardiovascular conditions remain a leading cause of mortality in India, the initiative seeks to advance evidence-based education and improve outcomes in cardiac care.
Dr. Sandeep Arora, Director, Medical Affairs at AstraZeneca Pharma India, said the programme reflects the company’s commitment to clinician-led education and capacity building. He noted that ICC combines real-world case discussions with transparent peer review from leading operators, helping accelerate the adoption of advanced interventional techniques aligned with global guidelines.
At the core of ICC is a distinguished faculty of 30 Course Principals who mentor participants and independently adjudicate submissions. The panel includes eminent cardiologists such as A. B. Mehta (Jaslok Hospital, Mumbai), D. S. Gambhir (Kailash Hospital, Noida), and Kamal Sharma (SAL Hospital, Ahmedabad), who also serves as Course Principal and Scientific Lead.
The programme has already drawn over 120 complex PCI case submissions from across the country, signalling strong demand for structured, high-quality, case-based learning in interventional cardiology.
“ICC is a movement to elevate cardiac care,” said Prof. Dr Kamal Sharma, Course Principal and Scientific Lead- ICC. “By taking this exchange fully virtual, high‑level expertise in complex PCI becomes accessible nationwide, accelerating evidence adoption and better outcomes.” Prof. Dr. Akshaya Pradhan added, “By pairing seasoned operators with emerging specialists, we can push the boundaries of cardiovascular care through mentorship and innovation.”